|
WO2019195609A2
(en)
|
2018-04-04 |
2019-10-10 |
Arvinas Operations, Inc. |
Modulators of proteolysis and associated methods of use
|
|
JP2025510572A
(ja)
|
2022-03-08 |
2025-04-15 |
レボリューション メディシンズ インコーポレイテッド |
免疫不応性肺癌を治療するための方法
|
|
AU2023231139A1
(en)
|
2022-03-11 |
2024-09-05 |
Kumquat Biosciences Inc. |
Heterocyclic compounds and uses thereof
|
|
WO2023240263A1
(en)
|
2022-06-10 |
2023-12-14 |
Revolution Medicines, Inc. |
Macrocyclic ras inhibitors
|
|
IL318647A
(en)
|
2022-08-05 |
2025-03-01 |
Kumquat Biosciences Inc |
Heterocyclic compounds and their uses
|
|
AU2023320914A1
(en)
*
|
2022-08-11 |
2025-02-27 |
Beone Medicines I Gmbh |
Heterocyclic compounds, compositions thereof, and methods of treatment therewith
|
|
WO2024041573A1
(en)
*
|
2022-08-25 |
2024-02-29 |
Zai Lab (Shanghai) Co., Ltd. |
Fused multi-heterocyclic compounds as kras g12d modulators and uses thereof
|
|
AU2023363515A1
(en)
*
|
2022-10-18 |
2025-04-17 |
Idience Co., Ltd. |
Novel triheterocyclic compounds
|
|
JP2025535367A
(ja)
*
|
2022-10-19 |
2025-10-24 |
ジェネンテック， インコーポレイテッド |
６－アザ部分を含むオキサゼピン化合物およびその使用
|
|
TW202430179A
(zh)
|
2022-11-21 |
2024-08-01 |
美商樹線生物科學公司 |
螺環二氫哌喃并嘧啶ＫＲａｓ抑制劑
|
|
WO2024153180A1
(zh)
*
|
2023-01-18 |
2024-07-25 |
上海艾力斯医药科技股份有限公司 |
杂环类化合物、其药物组合物及其用途
|
|
US12448399B2
(en)
|
2023-01-26 |
2025-10-21 |
Arvinas Operations, Inc. |
Cereblon-based KRAS degrading PROTACs and uses related thereto
|
|
WO2024197503A1
(en)
*
|
2023-03-27 |
2024-10-03 |
Nikang Therapeutics , Inc. |
Tricyclic derivatives as kras inhibitors
|
|
AU2024241633A1
(en)
|
2023-03-30 |
2025-11-06 |
Revolution Medicines, Inc. |
Compositions for inducing ras gtp hydrolysis and uses thereof
|
|
AR132338A1
(es)
|
2023-04-07 |
2025-06-18 |
Revolution Medicines Inc |
Inhibidores de ras
|
|
CR20250420A
(es)
|
2023-04-07 |
2025-11-20 |
Revolution Medicines Inc |
Inhibidores macrocíclicos de ras
|
|
CN121100123A
(zh)
|
2023-04-14 |
2025-12-09 |
锐新医药公司 |
Ras抑制剂的结晶形式
|
|
CN121464140A
(zh)
|
2023-04-14 |
2026-02-03 |
锐新医药公司 |
Ras抑制剂的结晶形式、含有其的组合物及其使用方法
|
|
TW202508595A
(zh)
|
2023-05-04 |
2025-03-01 |
美商銳新醫藥公司 |
用於ｒａｓ相關疾病或病症之組合療法
|
|
CN121194980A
(zh)
*
|
2023-05-16 |
2025-12-23 |
和记黄埔医药（上海）有限公司 |
三环类化合物及其用途
|
|
CN121605110A
(zh)
*
|
2023-06-06 |
2026-03-03 |
金橘生物科技公司 |
取代杂环化合物及其用途
|
|
CN121263417A
(zh)
*
|
2023-06-30 |
2026-01-02 |
金橘生物科技公司 |
取代的稠合三环胺化合物及其作为ras抑制剂的用途
|
|
CN116903499B
(zh)
*
|
2023-07-11 |
2025-05-30 |
上海应用技术大学 |
无水氟磺酰基二氟乙酸铜盐及其制备方法与应用
|
|
US20250049810A1
(en)
|
2023-08-07 |
2025-02-13 |
Revolution Medicines, Inc. |
Methods of treating a ras protein-related disease or disorder
|
|
WO2025038936A1
(en)
|
2023-08-17 |
2025-02-20 |
Treeline Biosciences, Inc. |
Spirocyclic dihydropyranopyrimidine kras inhibitors
|
|
TW202528315A
(zh)
|
2023-09-21 |
2025-07-16 |
美商樹線生物科學公司 |
螺環二氫哌喃并吡啶ＫＲａｓ抑制劑
|
|
AU2024360465A1
(en)
|
2023-10-12 |
2026-04-09 |
Revolution Medicines, Inc. |
Macrocyclic ras inhibitors
|
|
WO2025096738A1
(en)
*
|
2023-11-01 |
2025-05-08 |
Incyte Corporation |
Kras inhibitors
|
|
WO2025111586A1
(en)
|
2023-11-22 |
2025-05-30 |
Genentech, Inc. |
Polymorphs of and synthetic process for an aza-tetracyclic oxazepine inhibitor of kras-g12d
|
|
WO2025130912A1
(zh)
*
|
2023-12-19 |
2025-06-26 |
正大天晴药业集团股份有限公司 |
三并环类化合物及其医药用途
|
|
WO2025167948A1
(zh)
*
|
2024-02-06 |
2025-08-14 |
上海齐鲁制药研究中心有限公司 |
嘧啶并大环类kras抑制剂
|
|
WO2025168072A1
(en)
*
|
2024-02-08 |
2025-08-14 |
Beigene (Suzhou) Co., Ltd. |
Heterocyclic compounds, compositions thereof, and methods of treatment therewith
|
|
WO2025171296A1
(en)
|
2024-02-09 |
2025-08-14 |
Revolution Medicines, Inc. |
Ras inhibitors
|
|
TW202547461A
(zh)
|
2024-05-17 |
2025-12-16 |
美商銳新醫藥公司 |
Ｒａｓ抑制劑
|
|
WO2025245127A1
(en)
|
2024-05-21 |
2025-11-27 |
Treeline Biosciences, Inc. |
Spirocyclic dihydropyranopyrimidine kras inhibitors
|
|
WO2025255438A1
(en)
|
2024-06-07 |
2025-12-11 |
Revolution Medicines, Inc. |
Methods of treating a ras protein-related disease or disorder
|
|
WO2025265060A1
(en)
|
2024-06-21 |
2025-12-26 |
Revolution Medicines, Inc. |
Therapeutic compositions and methods for managing treatment-related effects
|
|
WO2026006747A1
(en)
|
2024-06-28 |
2026-01-02 |
Revolution Medicines, Inc. |
Ras inhibitors
|
|
WO2026015801A1
(en)
|
2024-07-12 |
2026-01-15 |
Revolution Medicines, Inc. |
Methods of treating a ras related disease or disorder
|
|
WO2026015796A1
(en)
|
2024-07-12 |
2026-01-15 |
Revolution Medicines, Inc. |
Methods of treating a ras related disease or disorder
|
|
WO2026015790A1
(en)
|
2024-07-12 |
2026-01-15 |
Revolution Medicines, Inc. |
Methods of treating a ras related disease or disorder
|
|
WO2026015825A1
(en)
|
2024-07-12 |
2026-01-15 |
Revolution Medicines, Inc. |
Use of ras inhibitor for treating pancreatic cancer
|
|
WO2026050446A1
(en)
|
2024-08-29 |
2026-03-05 |
Revolution Medicines, Inc. |
Ras inhibitors
|
|
WO2026072904A2
(en)
|
2024-09-26 |
2026-04-02 |
Revolution Medicines, Inc. |
Compositions and methods for treating lung cancer
|